CD36 and gastric cancer: Similarly, gene expression analysis performed on the TCGA-STAD cohort showed overexpression of CD36 in SARIFA-positive cases, indicating fatty acid metabolism changes in SARIFA areas, which is consistent with previous findings in gastric cancer [16].